{"nct_id":"NCT03162796","title":"A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)","status":"COMPLETED","status_verified_date":"2021-01","start_date":"2017-08-24","start_date_type":"ACTUAL","primary_completion_date":"2019-03-14","primary_completion_date_type":"ACTUAL","completion_date":"2019-11-18","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}